We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$268B
AUM Growth
+$39.7B
Cap. Flow
+$21.8B
Cap. Flow %
8.14%
Top 10 Hldgs %
12.83%
Holding
12,049
New
1,180
Increased
5,215
Reduced
3,564
Closed
1,371

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$850M
2
AAPL icon
Apple
AAPL
+$778M
3
TSLA icon
Tesla
TSLA
+$569M
4
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$351M
5
JNJ icon
Johnson & Johnson
JNJ
+$336M

Sector Composition

Rank Sector Weight
1 Technology 10.83%
2 Healthcare 7.49%
3 Financials 7.15%
4 Consumer Discretionary 4.92%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FGNX
9501
FG Nexus Inc
FGNX
$44.9M
$3.04K ﹤0.01%
9
+5
+125% +$1.4K
TLIS
9502
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$3.04K ﹤0.01%
450
+448
+22,400% +$3.93K
MOR
9503
DELISTED
MorphoSys AG American Depositary Shares
MOR
$3.01K ﹤0.01%
842
-4,299
-84% -$19.2K
PKBO
9504
DELISTED
Peak Bio, Inc. Common Stock
PKBO
$3.01K ﹤0.01%
719
-1,662
-70% -$11.5K
UK icon
9505
Ucommune International Ltd Class A Ordinary Shares
UK
$1.43M
$3.01K ﹤0.01%
17
+4
+31% +$951
EDTK icon
9506
Skillful Craftsman
EDTK
$15.1M
$3.01K ﹤0.01%
2,089
-12,124
-85% -$12.9K
PSFE.WS
9507
DELISTED
Paysafe Ltd Warrants
PSFE.WS
$3K ﹤0.01%
49,941
+31,270
+167% +$3K
GASS icon
9508
StealthGas
GASS
$318M
$2.99K ﹤0.01%
1,116
-5,106
-82% -$15.3K
ABTC
9509
American Bitcoin Corp
ABTC
$477M
$2.98K ﹤0.01%
+3
New +$6.22K
ABEO icon
9510
Abeona Therapeutics
ABEO
$388M
$2.98K ﹤0.01%
+967
New +$3.62K
INZY
9511
DELISTED
Inozyme Pharma
INZY
$2.98K ﹤0.01%
+2,834
New +$4.95K
HYGW icon
9512
iShares High Yield Corporate Bond BuyWrite Strategy ETF
HYGW
$112M
$2.97K ﹤0.01%
+82
New +$3.04K
FSNB
9513
DELISTED
Fusion Acquisition Corp. II
FSNB
$2.97K ﹤0.01%
296
-100
-25% -$994
HOWL icon
9514
Werewolf Therapeutics
HOWL
$19.5M
$2.97K ﹤0.01%
1,448
-1,002
-41% -$2.62K
BCTXW
9515
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$2.97K ﹤0.01%
1,441
-1,492
-51% -$3.48K
EVOK
9516
DELISTED
Evoke Pharma
EVOK
$2.97K ﹤0.01%
92
XBIOW
9517
DELISTED
Xenetic Biosciences, Inc. Warrants
XBIOW
$2.95K ﹤0.01%
1,477
+100
+7% +$88
CCAI
9518
DELISTED
Cascadia Acquisition Corp. Class A Common Stock
CCAI
$2.95K ﹤0.01%
294
QSIAW
9519
DELISTED
Quantum-Si Inc Warrant
QSIAW
$2.94K ﹤0.01%
11,767
+10,168
+636% +$4.46K
FICV
9520
DELISTED
Frontier Investment Corp Class A Ordinary Shares
FICV
$2.94K ﹤0.01%
+293
New +$2.91K
DVND icon
9521
Touchstone Dividend Select ETF
DVND
$54.6M
$2.94K ﹤0.01%
116
-19
-14% -$471
JGGC
9522
DELISTED
Jaguar Global Growth Corporation I Class A Ordinary Shares
JGGC
$2.93K ﹤0.01%
287
+200
+230% +$2.03K
DIVD icon
9523
Altrius Global Dividend ETF
DIVD
$21.4M
$2.92K ﹤0.01%
+102
New +$2.81K
CNSP icon
9524
CNS Pharmaceuticals
CNSP
$7.89M
0
TMCWW
9525
TMC The Metals Company Warrants
TMCWW
$455K
$2.91K ﹤0.01%
+36,390
New +$4.36K

Similar funds

UBS Group's Q4 2022 Portfolio in Review

As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,215 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.

  • UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
  • UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
  • UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
  • UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
  • UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
  • UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
  • UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.